論文・技術情報追加のお知らせ

1. Pharmacovigilance Insights into Route-Stratified Adverse Events of Platinum-Based Drugs.

白金系抗がん剤の投与経路別副作用と発現時期のFAERS解析。

対象DB：FAERS

2. Early post-marketing safety profile of resmetirom in FAERS: an exploratory assessment of statin co-reporting.

レスメチロムの初期安全性とスタチン併用に関するFAERS評価。

対象DB：FAERS

3. Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

GLP-1受容体作動薬の注射部位・皮膚副作用に関するFAERS解析。

対象DB：FAERS

4. Comparative safety signal prioritization of CDK4/6 inhibitors in breast cancer: a FAERS pharmacovigilance, machine learning, and clinical contextualization study.

乳がん治療でのCDK4/6阻害薬の安全性シグナル優先度評価。

対象DB：FAERS

5. Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation.

高齢者におけるプロトンポンプ阻害薬間の骨折リスク差異の解析。

対象DB：FAERS

6. Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.

GLP-1関連薬の糖尿病・肥満治療における市販後リスク評価。

対象DB：CVAR,FAERS

7. Antimicrobial-associated adverse events in neonates: an integrated literature review and FAERS pharmacovigilance analysis.

新生児における抗菌薬有害事象の文献調査およびFAERS解析。

対象DB：FAERS

8. Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data.

前立腺がん治療でのGnRH拮抗薬と作動薬の副作用比較解析。

対象DB：FAERS

9. Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data.

S1P受容体調節薬に伴う不整脈のリアルワールド不均衡分析。

対象DB：FAERS

10. Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study.

GLP-1受容体作動薬に伴う胃食道逆流症の多国間DB検証。

対象DB：CVAR,FAERS,JADER,KAERS

11. Risk assessment of infections and infestations associated with second-generation antipsychotics: A comprehensive analysis of the FAERS database.

第二世代抗精神病薬に伴う感染症関連有害事象のFAERS解析。

対象DB：FAERS,JADER

12. Safety analysis of acyclovir use in neonates based on the FDA Adverse Event Reporting System: A retrospective observational pharmacovigilance study.

新生児におけるアシクロビル使用のFAERS安全性評価。

対象DB：FAERS

13. A retrospective study of disproportionality analysis signals between proprotein convertase subtilisin/kexin 9 inhibitor use and respiratory, thoracic, and mediastinal disorders.

PCSK9阻害薬使用に伴う呼吸器・胸郭等障害のシグナル解析。

対象DB：FAERS

14. Real-World Safety Signals of Fluoroquinolone-Associated Peripheral Neuropathy: Analysis of US and Canadian Databases Combined with Mechanistic Exploration.

ニューキノロン系抗菌薬による末梢神経障害の不均衡分析。

対象DB：CVAR,FAERS

15. Anthracycline Cardiotoxicity: A Real-World Study Based on FDA Adverse Event Reporting System Database.

FAERSデータベースに基づくアンスラサイクリン心毒性解析。

対象DB：FAERS

16. Seizure-related phenomena associated with propofol: insights from the FDA Adverse Event Reporting System (FAERS).

FAERSデータを用いたプロポフォール関連けいれん現象解析。

対象DB：FAERS

17. Differential signal strength of male sexual dysfunction associated with antidepressants: a disproportionality analysis of FAERS database.

抗うつ薬に関連する男性性機能障害シグナル強度の不均衡分析。

対象DB：FAERS

18. Disproportionate reporting of euglycaemic and diabetic ketoacidosis with SGLT-2 inhibitors across expanding cardiorenal indications: a cross-database study of FAERS and JADER.

SGLT2阻害薬適応拡大でのケトアシドーシス報告の二国間解析。

対象DB：JADER

19. Incidence and Risk Factors for Invasive Mechanical Ventilation Dependency in Japan: A Nationwide Retrospective Cohort Study.

日本における侵襲的人工呼吸器依存の発生率とリスク因子の調査。

対象DB：DPC

20. Comparison of Perioperative Complications of Early-Stage Endometrial Cancer Between Laparotomy, Laparoscopic, and Robotic-assisted Surgery using DPC Data: A Retrospective Cohort Study in Japan.

早期体がん手術3術式における周術期合併症のDPCデータ比較。

対象DB：DPC

21. In-hospital mortality after transcatheter aortic valve implantation versus surgical aortic valve replacement in maintenance hemodialysis patients: a Japanese nationwide retrospective cohort study.

透析患者におけるTAVI対SAVRの院内死亡率比較全国調査。

対象DB：DPC

22. Association between Bacterial Culture before Carbapenem Use and Treatment Duration and Clinical Outcomes: A Nationwide Inpatient Claims Database Study in Japan.

カルバペネム開始前細菌培養と投与期間・転帰の関連性評価。

対象DB：DPC

23. Laparoscopic liver resection for patients with intrahepatic cholangiocarcinoma using data from the Japanese National Database: A nationwide observational study.

NDBを用いた肝内胆管がんにおける腹腔鏡下肝切除術の全国調査。

対象DB：NDB

24. Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.

進行パーキンソン病におけるホスレボドパ持続皮下注の実態調査。

対象DB：MDV

25. The incidence rates and prevalence of treated glaucoma in the United Kingdom, 2000-2022.

英国における治療対象緑内障の発症率および有病率の経時的推移。

対象DB：CPRD

26. Assessing the public health impact of routinely collected electronic healthcare record data in NICE guidelines: A systematic review of CPRD research.

NICEガイドラインにおけるCPRDデータ活用に関する評価。

対象DB：CPRD

27. Risk of venous thromboembolism after knee, hip, or shoulder arthroplasty : a retrospective cohort study of 476,620 procedures using linked hospital and primary care data.

人工関節置換術後の静脈血栓塞栓症リスクとガイドラインの影響。

対象DB：CPRD

28. Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.

英国における妊婦への百日咳ワクチン接種の高い発症予防効果。

対象DB：CPRD

29. Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016-2026.

T細胞結合性二重特異性抗体に伴う標的特異的皮膚副作用の解析。

対象DB：CVAR

30. Real-world trends in radiotherapy modalities for esophageal cancer: analysis of a nationwide claims database in Japan.

日本における食道がん放射線治療手法のリアルワールド実態推移。

対象DB：DeSC

31. Corticosteroid Use and In-Hospital Mortality in Patients With Brain Abscess: A Target Trial Emulation.

脳膿瘍患者におけるステロイド使用と院内死亡率の関連性評価。

対象DB：DeSC